恶性疟原虫疟疾中的抗疟药物耐药性与死亡率 - Suppr

Suppr

超能文献

Antimalarial drug resistance and mortality in falciparum malaria.

作者信息

White N

出版信息

Trop Med Int Health. 1999 Jul;4(7):469-70. doi: 10.1046/j.1365-3156.1999.00435.x.

DOI:10.1046/j.1365-3156.1999.00435.x

PMID:10470336

Abstract

摘要

相似文献

Antimalarial drug resistance and mortality in falciparum malaria.恶性疟原虫疟疾中的抗疟药物耐药性与死亡率

Trop Med Int Health. 1999 Jul;4(7):469-70. doi: 10.1046/j.1365-3156.1999.00435.x.

Editorial: antimalarial drug discovery and design in the era of resistance.

Curr Pharm Des. 2013;19(2):264-5.

Helicases - feasible antimalarial drug target for Plasmodium falciparum.解旋酶——恶性疟原虫可行的抗疟药物靶点。

FEBS J. 2007 Sep;274(18):4699-704. doi: 10.1111/j.1742-4658.2007.06000.x.

[Is the in vivo test for resistance to antimalarial agents in malaria as defined by the WHO valid?].[世界卫生组织定义的疟疾抗疟药体内耐药性检测是否有效？]

Med Clin (Barc). 1992 Oct 10;99(11):436.

Epidemiological distribution of Plasmodium falciparum drug resistance in Brazil and its relevance to the treatment and control of malaria.巴西恶性疟原虫耐药性的流行病学分布及其与疟疾治疗和控制的相关性。

Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:343-8. doi: 10.1590/s0074-02761992000700058.

Antimalarial drug resistance: the pace quickens.

J Antimicrob Chemother. 1992 Nov;30(5):571-85. doi: 10.1093/jac/30.5.571.

Dynamics of Plasmodium falciparum selection after artemether-lumefantrine treatment in Africa.非洲青蒿琥酯-本芴醇治疗后恶性疟原虫的选择动态

J Infect Dis. 2012 May 1;205(9):1473-5; author reply 1475-6. doi: 10.1093/infdis/jis227. Epub 2012 Mar 27.

Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box.基于液相色谱-质谱联用技术对疟疾盒中一组抗疟药物进行初步筛选，以寻找恶性疟原虫硫氧还蛋白还原酶（PfTrxR）的抑制剂。

Molecules. 2016 Mar 28;21(4):424. doi: 10.3390/molecules21040424.

Understanding drug resistance in malaria parasites: basic science for public health.了解疟原虫的耐药性：公共卫生的基础科学。

Mol Biochem Parasitol. 2014 Jul;195(2):107-14. doi: 10.1016/j.molbiopara.2014.06.001. Epub 2014 Jun 10.

Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.恶性疟原虫和间日疟原虫抗疟耐药性的分子与生物学方面

Curr Drug Targets. 2009 Mar;10(3):279-90. doi: 10.2174/138945009787581131.

引用本文的文献

Compliance With Referral Advice After Treatment With Prereferral Rectal Artesunate: A Study in 3 Sub-Saharan African Countries.转诊前直肠青蒿琥酯治疗后对转诊建议的依从性：撒哈拉以南非洲3个国家的一项研究。

Clin Infect Dis. 2016 Dec 15;63(suppl 5):S283-S289. doi: 10.1093/cid/ciw627.

The niche reduction approach: an opportunity for optimal control of infectious diseases in low-income countries?小生境缩减方法：在低收入国家实现传染病最佳控制的机会？

BMC Public Health. 2014 Jul 25;14:753. doi: 10.1186/1471-2458-14-753.

Multiplicity of Plasmodium falciparum infection predicts antimalarial treatment outcome in Ugandan children.恶性疟原虫感染的多样性可预测乌干达儿童的抗疟治疗结果。

Afr Health Sci. 2008 Dec;8(4):200-5.

Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.在接受氯喹治疗的感染恶性疟原虫的苏丹患者中，pfcrt 等位基因 CVMNK 和 CVIET 的动态变化。

Malar J. 2010 Mar 12;9:74. doi: 10.1186/1475-2875-9-74.

Evolution of malaria mortality and morbidity after the emergence of chloroquine resistance in Niakhar, Senegal.在塞内加尔尼奥阿克出现氯喹耐药性后，疟疾死亡率和发病率的演变。

Malar J. 2009 Nov 27;8:270. doi: 10.1186/1475-2875-8-270.

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial.转诊前使用青蒿琥酯预防重症疟疾死亡和残疾：一项安慰剂对照试验。

Lancet. 2009 Feb 14;373(9663):557-66. doi: 10.1016/S0140-6736(08)61734-1. Epub 2008 Dec 6.

In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up.针对恶性疟原虫疟疾的药物疗效的体内评估：随访持续时间。

Antimicrob Agents Chemother. 2004 Nov;48(11):4271-80. doi: 10.1128/AAC.48.11.4271-4280.2004.

Identification and expression analysis of ABC genes in Plasmodium yoelii and P. berghei.约氏疟原虫和伯氏疟原虫中ABC基因的鉴定与表达分析

Parasitol Res. 2004 Jan;92(1):1-11. doi: 10.1007/s00436-003-1001-8. Epub 2003 Oct 17.

The de novo selection of drug-resistant malaria parasites.耐药疟原虫的从头选择。

Proc Biol Sci. 2003 Mar 7;270(1514):545-54. doi: 10.1098/rspb.2002.2241.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验